Easton, PA, United States of America

Ned D Heindel

This inventor holds 20 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Anti-Inflammatory Pharmaceuticals. Top assignees: Lehigh University, Rutgers, The State University of New Jersey, University of Medicine and Dentistry of New Jersey. Active years: 1990-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ned D Heindel. Retrieved from https://idiyas.com/inventor/ned-d-heindel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 75.0



Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 85(Granted Patents)


Location History:

  • Bethlehem, PA (US) (2011)
  • Easton, PA (US) (1990 - 2023)

Company Filing History:


Years Active: 1990-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-Inflammatory Compounds
Dual-Action Therapeutics
Fluorescent Tags
Vanilloid Hydroxamates
Triazole Derivatives
Psoralens
Cell Proliferation Inhibitors
Selective Inhibitors
20 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ned D. Heindel in Anti-Inflammatory Compounds

Introduction: Ned D. Heindel, based in Easton, PA, is a prolific inventor with a remarkable portfolio of 20 patents. His work primarily focuses on enhancing anti-inflammatory compounds, making significant strides in the field of biomedical research.

Latest Patents: Among his latest patents, Heindel has developed augmented or synergized anti-inflammatory constructs. These constructs include anti-inflammatory terpenes and/or vanilloids that are covalently conjugated together, maximizing their efficacy beyond the sum of their individual activities. He has also disclosed innovative methods for enhancing the potency of anti-inflammatory terpenes or vanilloids by linking them through carbamate linkages, further enriching their therapeutic potentials. Moreover, his research encompasses conjugation of anti-inflammatory amino acids with other therapeutic molecules, such as nonsteroidal anti-inflammatory drugs and ketone bodies, thereby amplifying the anti-inflammatory effects.

Career Highlights: Ned D. Heindel has had an impressive career, notably with his involvement in esteemed institutions like Lehigh University and Rutgers, The State University of New Jersey. His contributions to the field have established him as a key figure in the development of new anti-inflammatory therapies.

Collaborations: Throughout his career, Heindel has collaborated with notable colleagues such as Jeffrey D. Laskin and Diane E. Heck. These partnerships have enriched his research and expanded the scope of his innovations, reinforcing the importance of collaborative efforts in scientific advancements.

Conclusion: Ned D. Heindel's inventive work has significantly influenced the landscape of anti-inflammatory compounds. His patented innovations not only reflect his commitment to enhancing therapeutic modalities but also underscore the vital role of collaboration in driving scientific progress. As the demand for effective anti-inflammatory treatments continues to grow, Heindel's pioneering contributions are poised to make lasting impacts in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…